Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells

Cancer therapy is often hampered by the disease’s development of resistance to anticancer drugs. We previously showed that the autonomously upregulated product of fibroblast growth factor 13 gene (FGF13; also known as FGF homologous factor 2 (FHF2)) is responsible for the cisplatin resistance of HeL...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Nobuki, Ebihara, Miku, Oishi, Shiori, Fujimoto, Yuku, Okada, Tomoko, Imamura, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810706/
https://www.ncbi.nlm.nih.gov/pubmed/33452347
http://dx.doi.org/10.1038/s41598-021-81077-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810706/
https://www.ncbi.nlm.nih.gov/pubmed/33452347
http://dx.doi.org/10.1038/s41598-021-81077-y

Ejemplares similares